Dexcom Unveils Artificial Intelligence Feature for Stelo Continuous Glucose Monitor
Dexcom has announced an artificial intelligence feature for its Stelo continuous glucose monitor, which provides users with a personalized look at how meals, sleep, and activity impact their glucose levels. This is the first iteration of a new generative AI platform that the company has been building with Google Cloud.
Stelo is an over-the-counter CGM that measures real-time blood sugar levels and was launched in August. The new AI feature uses Google’s Gemini models and Vertex AI platform to synthesize different types of data and provide users with a personalized report.
The report is designed to be more engaging and valuable to users, providing relevant tips and educational materials based on their individual data. For example, if a user is not moving enough after meals, the report would include suggestions for improvement.
Dexcom is using the AI framework from the U.S. Food and Drug Administration to guide the development of the feature, which does not provide medical advice. The company plans to use the generative AI platform to deliver real-time feedback to users and potentially act as a predictive indicator for potential problems.
The updated weekly report began rolling out to Stelo users this week, marking the first iteration of the company’s new AI platform. Dexcom is exploring how the technology can be used across its other CGM products, but is proceeding with caution due to the critical nature of these devices.